Technical Analysis for MRKR - Marker Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 5.52 15.00% 0.72
MRKR closed up 15.0 percent on Friday, August 16, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical MRKR trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
New Uptrend Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 15.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 15.00%
Wide Bands Range Expansion 15.00%
1,2,3 Retracement Bearish Bearish Swing Setup 19.48%

Older signals for MRKR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its cell therapy technology is based on the tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. The company is also advancing various peptide- and gene-based immuno-therapeutics for the treatment of cancer and metastatic disease, including its Folate Receptor Alpha program (TPIV200) for breast and ovarian cancers and HER2/neu+ peptide antigen program (TPIV100/110) in Phase II clinical trials. In addition, it develops a proprietary DNA expression technology, known as PolyStart, to improve the ability of the cellular immune system to recognize and destroy diseased cells. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
Medicine Cancer Immunology Treatment Of Cancer Oncology Immunotherapy Immune System Cancer Treatments Cancer Immunotherapy Virotherapy Tumor Immunotherapies Cell Therapy Solid Tumor Hematological Malignancies T Cell
Is MRKR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.6
52 Week Low 3.97
Average Volume 814,199
200-Day Moving Average 6.1494
50-Day Moving Average 6.4488
20-Day Moving Average 4.876
10-Day Moving Average 4.63
Average True Range 0.4672
ADX 38.17
+DI 26.0346
-DI 22.979
Chandelier Exit (Long, 3 ATRs ) 7.378399999999999
Chandelier Exit (Short, 3 ATRs ) 5.3716
Upper Bollinger Band 5.9589
Lower Bollinger Band 3.7931
Percent B (%b) 0.8
BandWidth 44.417555
MACD Line -0.5199
MACD Signal Line -0.6504
MACD Histogram 0.1305
Fundamentals Value
Market Cap 56.07 Million
Num Shares 10.2 Million
EPS -1.02
Price-to-Earnings (P/E) Ratio -5.41
Price-to-Sales 0.00
Price-to-Book 3.74
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.54
Resistance 3 (R3) 6.49 6.09 6.37
Resistance 2 (R2) 6.09 5.83 6.12 6.31
Resistance 1 (R1) 5.81 5.67 5.95 5.86 6.26
Pivot Point 5.41 5.41 5.49 5.44 5.41
Support 1 (S1) 5.13 5.15 5.27 5.18 4.78
Support 2 (S2) 4.73 4.99 4.76 4.73
Support 3 (S3) 4.45 4.73 4.67
Support 4 (S4) 4.50